• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腺中的生长抑素受体。

Somatostatin receptors in the thymus.

作者信息

Ferone D, van Hagen P M, Colao A, Annunziato L, Lamberts S W, Hofland L J

机构信息

Department of Internal Medicine III, Erasmus University, Rotterdam, The Netherlands.

出版信息

Ann Med. 1999 Oct;31 Suppl 2:28-33.

PMID:10574152
Abstract

The thymus is the primary lymphoid organ where different factors participate in regulating the proliferation and differentiation of T cells. The thymic epithelium is the main cellular component in driving the maturation of thymocytes through cell-to-cell and extracellular matrix-mediated interactions. Thymic hormones and cytokines play a critical role in the proliferation, differentiation and selection of precursor cells along the T-cell lineage. However, other locally produced hormones and neuropeptides participate in thymic functions in an autocrine and paracrine manner. Some of them have well-characterized actions, whereas somatostatin (SS), although it has been identified, has not been investigated in detail. SS inhibits hormone and exocrine secretion, modulates neurotransmission and inhibits cell proliferation. The biological effects of SS are mediated through five G protein-coupled membrane receptor subtypes (sst1-5). SS receptors (SS-R) have been demonstrated in normal tissues and tumours at the protein and mRNA levels. Sst2 mRNA has been detected in the murine thymus, whereas sst3 and sst4 mRNAs are expressed in the rat immune system. The significance of the presence of specific SS-R subtypes remains to be clarified. Moreover, the activation of lymphoid cells seems to modify their SS-R expression pattern. SS, sst1, sst2A and sst3 mRNAs have been found in normal human thymic tissue, whereas enriched cultured thymic epithelial cells (TEC) selectively express SS, sst1 and sst2A mRNAs. Furthermore, TEC respond in vitro to SS and octreotide by inhibiting cell proliferation. Immunoreactivity for sst2A has been detected primarily in the medulla, where TEC, dendritic cells and macrophages are the major components, in line with the predominant binding of the sst2 receptor-preferring ligand [125I-Tyr3]-octreotide in this region. The heterogeneous distribution of SS-R subtypes on specific cell subsets indicates that SS may play a paracrine and/or autocrine role in regulating cell activities in the thymus.

摘要

胸腺是主要的淋巴器官,不同因素参与调节T细胞的增殖和分化。胸腺上皮是通过细胞间和细胞外基质介导的相互作用驱动胸腺细胞成熟的主要细胞成分。胸腺激素和细胞因子在T细胞谱系前体细胞的增殖、分化和选择中起关键作用。然而,其他局部产生的激素和神经肽以自分泌和旁分泌方式参与胸腺功能。其中一些具有明确的作用,而生长抑素(SS)虽然已被鉴定,但尚未进行详细研究。SS抑制激素和外分泌分泌,调节神经传递并抑制细胞增殖。SS的生物学效应通过五种G蛋白偶联膜受体亚型(sst1 - 5)介导。SS受体(SS - R)已在正常组织和肿瘤中在蛋白质和mRNA水平得到证实。在小鼠胸腺中检测到sst2 mRNA,而sst3和sst4 mRNA在大鼠免疫系统中表达。特定SS - R亚型存在的意义仍有待阐明。此外,淋巴细胞的激活似乎会改变其SS - R表达模式。在正常人胸腺组织中发现了SS、sst1、sst2A和sst3 mRNA,而富集培养的胸腺上皮细胞(TEC)选择性表达SS、sst1和sst2A mRNA。此外,TEC在体外对SS和奥曲肽有反应,通过抑制细胞增殖。主要在髓质中检测到sst2A的免疫反应性,其中TEC、树突状细胞和巨噬细胞是主要成分,这与该区域sst2受体偏好配体[125I - Tyr3] - 奥曲肽的主要结合情况一致。SS - R亚型在特定细胞亚群上的异质性分布表明,SS可能在调节胸腺细胞活动中发挥旁分泌和/或自分泌作用。

相似文献

1
Somatostatin receptors in the thymus.胸腺中的生长抑素受体。
Ann Med. 1999 Oct;31 Suppl 2:28-33.
2
Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes.生长抑素受体亚型在人胸腺细胞中的定量及功能表达
Am J Physiol Endocrinol Metab. 2002 Nov;283(5):E1056-66. doi: 10.1152/ajpendo.00205.2001.
3
In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells.人胸腺中生长抑素受体的体外特性以及生长抑素和奥曲肽对培养的胸腺上皮细胞的影响。
Endocrinology. 1999 Jan;140(1):373-80. doi: 10.1210/endo.140.1.6398.
4
Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.生长抑素类似物的潜在适应证:免疫系统和淋巴增殖性疾病。
J Endocrinol Invest. 2005;28(11 Suppl International):111-7.
5
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.神经内分泌-免疫相互作用:可体松抑制素/生长抑素系统的作用
Ann N Y Acad Sci. 2006 Jun;1069:129-44. doi: 10.1196/annals.1351.011.
6
The elusive nature of cerebellar somatostatin receptors: studies in rat, monkey and human cerebellum.小脑生长抑素受体难以捉摸的特性:对大鼠、猴子和人类小脑的研究
J Recept Signal Transduct Res. 1997 Jan-May;17(1-3):385-405. doi: 10.3109/10799899709036616.
7
Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation.生长抑素受体亚型sst1 - sst5在大鼠延髓参与自主神经调节区域的表达及定位
J Chem Neuroanat. 2008 Jan;35(1):49-66. doi: 10.1016/j.jchemneu.2007.06.002. Epub 2007 Jun 27.
8
Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.人类胸腺瘤中的生长抑素受体亚型及奥曲肽在体外对细胞增殖的抑制作用。
J Clin Endocrinol Metab. 2000 Apr;85(4):1719-26. doi: 10.1210/jcem.85.4.6547.
9
[Somatostatin receptors in immune system cells].[免疫系统细胞中的生长抑素受体]
Minerva Endocrinol. 2001 Sep;26(3):165-73.
10
The role of cortistatin in the human immune system.皮质抑素在人体免疫系统中的作用。
Mol Cell Endocrinol. 2008 May 14;286(1-2):141-7. doi: 10.1016/j.mce.2008.03.007. Epub 2008 Mar 27.

引用本文的文献

1
The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?奥曲肽在胸腺瘤治疗中的漫长历史:一种古老药物还是当代药物?
Cancers (Basel). 2022 Feb 2;14(3):774. doi: 10.3390/cancers14030774.
2
Thymic pathologies in myasthenia gravis: a preoperative assessment of CAT scan and nuclear based imaging.重症肌无力的胸腺病理学:CAT 扫描和核素成像的术前评估。
J Neurol. 2016 Apr;263(4):641-8. doi: 10.1007/s00415-016-8023-5. Epub 2016 Jan 25.
3
Neuronostatin inhibits cardiac contractile function via a protein kinase A- and JNK-dependent mechanism in murine hearts.
在小鼠心脏中,神经抑素通过蛋白激酶A和JNK依赖性机制抑制心脏收缩功能。
Am J Physiol Regul Integr Comp Physiol. 2009 Sep;297(3):R682-9. doi: 10.1152/ajpregu.00196.2009. Epub 2009 Jun 24.
4
Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome?奥曲肽在异位库欣综合征患者中是否具有治疗作用?
J Endocrinol Invest. 2003 Aug;26(8):710-7. doi: 10.1007/BF03347351.